Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

NCT07111494 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis (PsA)

Interventions

DRUG: GLP-1 agonists
OTHER: Nutrition Counseling

Sponsor

Medical College of Wisconsin